Table 2.
Baseline characteristics of patients with diabetes mellitus in 2011 and 2013
| IDMPS 2013 | IDMPS 2011 | |
| Total patients recruited | 596 | 1157 |
| Age in yr | 59.37 | 56.42 |
| Male/female, n/n | 289/307 | 588/569 |
| BMI, kg/m2 | 30.13 | 28.92 |
| BP control | ||
| Mean BP | 130.03/77.89 | 130.8/79.7 |
| SBP < 130, % | 40.2 | 43.7 |
| DBP < 80, % | 39.8 | 33 |
| HTN treatment | ||
| ACEI, % | 33.3 | 36.2 |
| ARB, % | 50 | 50.1 |
| Antiplatelet therapy, % | 42.4 | 45.7 |
| Dyslipidemia and management | ||
| Diagnosed with dyslipidemia, % | 68.3 | 68 |
| LDL < 100 mg/dL, % | 39.2 | 39.3 |
| HDL ≥ 40 mg/dL, % | 68.5 | 62.7 |
| TG < 150 mg/dL, % | 44.4 | 39 |
| Statin therapy, % | 86.5 | 82.7 |
| Glycemic control | ||
| Mean HbA1c | 7.98 | 7.79 |
| HbA1c < 7%, % | 31.4 | 36.1 |
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HTN: Hypertension; ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin II receptor blockers; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; TG: Triglycerides; HbA1c: Glycosylated hemoglobin.